These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20490489)

  • 1. Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice.
    Rocha FG; Chaves KC; Chammas R; Peron JP; Rizzo LV; Schor N; Bellini MH
    Cancer Immunol Immunother; 2010 Sep; 59(9):1357-65. PubMed ID: 20490489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma.
    de Souza Braga M; Chaves KB; Chammas R; Schor N; Bellini MH
    Biomed Pharmacother; 2012 Jun; 66(4):237-41. PubMed ID: 22560459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model.
    Chaves KC; Peron JP; Chammas R; Turaça LT; Pesquero JB; Braga MS; Foguer K; Schor N; Bellini MH
    Cancer Gene Ther; 2012 Aug; 19(8):558-65. PubMed ID: 22699868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy.
    Chaves KC; Turaça LT; Pesquero JB; Mennecier G; Dagli ML; Chammas R; Schor N; Bellini MH
    Biomed Pharmacother; 2012 Sep; 66(6):464-8. PubMed ID: 22920414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endostatin gene therapy inhibits intratumoral macrophage M2 polarization.
    Foguer K; Braga Mde S; Peron JP; Bortoluci KR; Bellini MH
    Biomed Pharmacother; 2016 Apr; 79():102-11. PubMed ID: 27044818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells.
    Weiss JM; Shivakumar R; Feller S; Li LH; Hanson A; Fogler WE; Fratantoni JC; Liu LN
    Cancer Gene Ther; 2004 May; 11(5):346-53. PubMed ID: 15031722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma.
    Rocha FG; Calvo FB; Chaves KC; Peron JP; Marques RF; de Borba TR; Braga MS; Pereira CB; Vicente EJ; Chammas R; Schor N; Bellini MH
    J Gene Med; 2011 Mar; 13(3):148-57. PubMed ID: 21344541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model.
    Hillman GG; Younes E; Visscher D; Ali E; Lam JS; Montecillo E; Pontes JE; Haas GP; Puri RK
    Cell Immunol; 1995 Feb; 160(2):257-63. PubMed ID: 7720087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model.
    Kroeze SG; Daenen LG; Nijkamp MW; Roodhart JM; de Gast GC; Bosch JL; Jans JJ
    J Urol; 2012 Aug; 188(2):607-14. PubMed ID: 22704448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor as a biomarker for endostatin gene therapy.
    Braga MS; Turaça TL; Foguer K; Chaves KC; Pesquero JB; Chammas R; Schor N; Bellini MH
    Biomed Pharmacother; 2013 Jul; 67(6):511-5. PubMed ID: 23726969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy.
    Norian LA; Kresowik TP; Rosevear HM; James BR; Rosean TR; Lightfoot AJ; Kucaba TA; Schwarz C; Weydert CJ; Henry MD; Griffith TS
    PLoS One; 2012; 7(2):e31085. PubMed ID: 22312440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo hydrodynamic delivery of cDNA encoding IL-2: rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells.
    Ortaldo JR; Winkler-Pickett RT; Bere EW; Watanabe M; Murphy WJ; Wiltrout RH
    J Immunol; 2005 Jul; 175(2):693-9. PubMed ID: 16002664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines.
    Nishisaka N; Maini A; Kinoshita Y; Yasumoto R; Kishimoto T; Jones RF; Morse P; Hillman GG; Wang CY; Haas GP
    J Immunother; 1999 Jul; 22(4):308-14. PubMed ID: 10404432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma.
    Chaves KC; Costa EM; Teixeira LF; Bellini MH
    Exp Oncol; 2018 Mar; 40(1):24-32. PubMed ID: 29600976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of radiation and vaccination with autologous tumor cells expressing IL-2, IFN-gamma and GM-CSF for treatment of murine renal carcinoma.
    Maini A; Nishisaka N; Kinoshita Y; Jones RF; Wang CY; Haas GP
    In Vivo; 2003; 17(2):119-23. PubMed ID: 12792971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the NF-кB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma.
    de Souza Braga M; da Silva Paiva KB; Foguer K; Barbosa Chaves KC; de Sá Lima L; Scavone C; Bellini MH
    Biomed Pharmacother; 2014 Sep; 68(7):873-9. PubMed ID: 25113400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages.
    Fan K; Zhou M; Pathak MK; Lindner DJ; Altuntas CZ; Tuohy VK; Borden EC; Yi T
    J Immunol; 2005 Nov; 175(10):7003-8. PubMed ID: 16272361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
    BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.